Aziyo Biologics rebrands as Elutia; shifts to drug-eluting biomatrices; ticker now ELUT

ELUTIA INC.

Name change to Elutia Inc. effective Sept 6, 2023; ticker switches from AZYO to ELUT on Nasdaq on Sept 7.
Rebranding reflects strategic focus on drug-eluting biomatrix (DEB) technology to improve surgical outcomes.
First DEB product CanGaroo RM for pacemaker/defibrillator market expected to launch next year; market valued at $600M.
Developing SimpliDerm RM for breast reconstruction ($500M market) to address post-op infection rates exceeding 10%.
CEO Randy Mills highlights commitment to DEB technology; no immediate financial impact or guidance provided.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ELUTIA INC.: Company changed its corporate name from Aziyo Biologics, Inc. to Elutia Inc. by an amendment to its restated certificate of incorporation (effective 2023-09-06).

Change: charter amendment
Effective: 2023-09-06

Exact text from the filing

On September 6, 2023, Aziyo Biologics, Inc. (the “Company”) changed its corporate name to Elutia Inc., by an amendment to its restated certificate of incorporation filed with the Delaware Secretary of State (the “Name Change”).

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ELUTIA INC.: Company amended and restated its bylaws to reflect the name change to Elutia Inc (effective 2023-09-06).

Change: bylaw amendment
Effective: 2023-09-06

Exact text from the filing

The Company also amended and restated its bylaws to reflect the Name Change.

View on SEC.gov

Browse all governance changes →

ELUTIA INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-098809

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.